Skip to content

A Multicenter Retrospective Cohort Study of Clinical Features and Prognosis of Anti-DPPX Encephalitis

A Multicenter Retrospective Cohort Study of Clinical Features and Prognosis of Anti-DPPX Encephalitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128943
Enrollment
Unknown
Registered
2026-07-28
Start date
2024-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti-dppx antibody-related autoimmune encephalitis

Interventions

Observation group:None

Sponsors

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Autoimmune encephalitis was confirmed and positive for anti-DPPX antibodies; 2.Age >=14 years old;

Exclusion criteria

Exclusion criteria: 1.Case data were insufficient to collect the required clinical data;

Design outcomes

Primary

MeasureTime frame
Modified Rankin(mRS) scale;

Secondary

MeasureTime frame
Clinical data: Age, gender, duration of illness, clinical manifestations (weight loss, diarrhea, preceding infection, cognitive dysfunction, neuropsychiatric symptoms, autonomic nerve symptoms, etc.);Laboratory results (antibody levels in serum/cerebrospinal fluid, immunological indicators, rheumatic indicators, etc.);Imaging examinations (cranial MRI, PET);Electroencephalogram;

Countries

China

Contacts

Public ContactGuan Yangtai

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

yangtaiguan@hotmail.com+86 21 68343081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026